Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis
Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis
Extended lymph node removal does not benefit patients with clinically localised muscle-invasive bladder cancer
Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer
2L triple metronomic chemo shows more efficacy in comparison to systemic therapy for head and neck cancer
ASCO 2023: Breast cancer research highlights
Ciltacabtagene autoleucel greatly reduces risk of disease progression in lenalidomide-refractory MM
mRCC: Atezolizumab after progression with prior ICI treatment shows no benefit and increases toxicity
Effectiveness of a cardiovascular health EHR application for cancer survivors in community oncology practice
ASCO 2023: Head and neck highlights
Baseline liquid biopsy results in treatment efficacy of FOLFIRI/cetuximab in patients with tissue RAS-WT mCRC
Real-world behavioural restrictional practices of cancer patients
Elranatamab shows efficacy in RRMM with prior BCMA-directed treatment